SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Results of Operations and Financial Condition

SenesTech, Inc. (NASDAQ:SNES) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

Story continues below

On August 10, 2017, SenesTech, Inc. (the “Company”) announced its financial results for the three months ended June 30, 2017. A copy of the Company’s press release announcing these financial results and certain other information is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by this reference.

The information in this report shall not be deemed to be “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 2.02 Financial Statements and Exhibits.

(d) The following exhibit is furnished with this Form 8-K to Item 2.02:
ExhibitNo. Description
99.1 Press release dated August 10, 2017

SenesTech, Inc. Exhibit
EX-99.1 2 s107136_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1       SenesTech Announces Second Quarter Financial and Operational Results   FLAGSTAFF,…
To view the full exhibit click here

About SenesTech, Inc. (NASDAQ:SNES)

SenesTech, Inc. is a platform biotechnology company. The Company is engaged in developing a technology for managing animal pest populations through fertility control. Its approach is designed to manage food security and manage infrastructure damage, disease outbreaks, environmental contamination and other costs associated with rodent infestations. Its fertility control product candidate, ContraPest, will be marketed for use in controlling rat populations. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. The Company applies its technology to manage rats in urban and agricultural settings. It has a pipeline of fertility control and animal health products, which include ContraPest, Plant-based fertility control, Feral animal fertility control, Boar taint, and Non-Surgical Spay and Neutering.

An ad to help with our costs